FAM101A Inhibitors
Items 1 to 10 of 12 total
Display:
| Product Name | CAS # | Catalog # | QUANTITY | Price | Citations | RATING |
|---|---|---|---|---|---|---|
Oligomycin A | 579-13-5 | sc-201551 sc-201551A sc-201551B sc-201551C sc-201551D | 5 mg 25 mg 100 mg 500 mg 1 g | $179.00 $612.00 $1203.00 $5202.00 $9364.00 | 26 | |
Oligomycin A inhibits mitochondrial ATP synthase, which reduces ATP levels and consequently affects ATP-dependent pathways that FAM101A may be involved in, leading to functional inhibition of FAM101A's enzymatic activity. | ||||||
Concanamycin A | 80890-47-7 | sc-202111 sc-202111A sc-202111B sc-202111C | 50 µg 200 µg 1 mg 5 mg | $66.00 $167.00 $673.00 $2601.00 | 109 | |
Concanamycin A is a vacuolar-type H+-ATPase inhibitor, leading to disruption of proton gradients and cellular pH homeostasis, which can inhibit FAM101A's function that may rely on pH-sensitive mechanisms. | ||||||
Bortezomib | 179324-69-7 | sc-217785 sc-217785A | 2.5 mg 25 mg | $135.00 $1085.00 | 115 | |
Bortezomib inhibits the 26S proteasome, which can lead to an accumulation of polyubiquitinated proteins and possibly inhibit FAM101A by disrupting protein degradation pathways it may be involved in or reliant upon. | ||||||
Taxol | 33069-62-4 | sc-201439D sc-201439 sc-201439A sc-201439E sc-201439B sc-201439C | 1 mg 5 mg 25 mg 100 mg 250 mg 1 g | $41.00 $74.00 $221.00 $247.00 $738.00 $1220.00 | 39 | |
Paclitaxel stabilizes microtubules and can inhibit cell division. Disruption of cytoskeletal dynamics can indirectly inhibit FAM101A by affecting cellular processes that require FAM101A function for cell cycle progression. | ||||||
Dasatinib | 302962-49-8 | sc-358114 sc-358114A | 25 mg 1 g | $70.00 $145.00 | 51 | |
Dasatinib is a Src-family tyrosine kinase inhibitor, and by inhibiting these kinases, it can disrupt downstream signaling pathways where FAM101A is involved, resulting in functional inhibition of FAM101A. | ||||||
U-0126 | 109511-58-2 | sc-222395 sc-222395A | 1 mg 5 mg | $64.00 $246.00 | 136 | |
U0126 is an inhibitor of MEK1/2, which blocks the MAPK/ERK pathway. By inhibiting this pathway, it can functionally inhibit FAM101A if FAM101A is involved in cell signaling pathways that depend on MAPK/ERK signaling for activity. | ||||||
LY 294002 | 154447-36-6 | sc-201426 sc-201426A | 5 mg 25 mg | $123.00 $400.00 | 148 | |
LY294002 is a PI3K inhibitor, which can inhibit the PI3K/Akt pathway. This inhibition can lead to functional inhibition of FAM101A if FAM101A's activity is connected to or dependent on the PI3K/Akt signaling pathway. | ||||||
Rapamycin | 53123-88-9 | sc-3504 sc-3504A sc-3504B | 1 mg 5 mg 25 mg | $63.00 $158.00 $326.00 | 233 | |
Rapamycin inhibits mTOR, which is involved in cell growth and proliferation. By inhibiting mTOR, Rapamycin can functionally inhibit FAM101A activity indirectly if FAM101A is involved in pathways or processes regulated by mTOR. | ||||||
Thapsigargin | 67526-95-8 | sc-24017 sc-24017A | 1 mg 5 mg | $136.00 $446.00 | 114 | |
Thapsigargin is a SERCA pump inhibitor that leads to increased cytosolic calcium levels. This disruption can inhibit FAM101A if FAM101A's function is calcium-dependent or if it operates in calcium-regulated pathways. | ||||||
Staurosporine | 62996-74-1 | sc-3510 sc-3510A sc-3510B | 100 µg 1 mg 5 mg | $82.00 $153.00 $396.00 | 113 | |
Staurosporine is a potent kinase inhibitor and can functionally inhibit FAM101A by inhibiting kinases that phosphorylate FAM101A or kinases that are part of pathways where FAM101A is functionally active. | ||||||